Rchr
J-GLOBAL ID:201801011274034033   Update date: Jun. 21, 2024

Katagiri Toyomasa

カタギリ トヨマサ | Katagiri Toyomasa
Affiliation and department:
Homepage URL  (1): http://www.genome.tokushima-u.ac.jp/dgm/
Research field  (2): Pathobiochemistry ,  Tumor biology
Research keywords  (4): 癌抑制遺伝子 ,  分子標的 ,  ゲノム医科学 ,  分子腫瘍学
Research theme for competitive and other funds  (17):
  • 2023 - 2026 Mutant p53 - Cancer Immunology Research from the DDX31 axis
  • 2022 - 2025 Development of biomarkers and new treatments for metastatic breast cancer by eribulin
  • 2020 - 2025 Elucidating mechanisms of therapeutic resistance in breast cancer and the development of innovative therapeutic approach utilizing tumor suppressor activity
  • 2017 - 2022 Analysis of sorting zones involved in protein quality control in the endoplasmic reticulum
  • 2018 - 2021 Development of integrated treatment for impaired liver regeneration on non-alcoholic steatohepatitis
Show all
Papers (173):
  • Jirapat Namkaew, Jun Zhang, Norio Yamakawa, Yoshimasa Hamada, Kazue Tsugawa, Miho Oyadomari, Masato Miyake, Toyomasa Katagiri, Seiichi Oyadomari. Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer. Cancer letters. 2024. 582. 216509-216509
  • Hitomi Sudo, Atsushi B Tsuji, Aya Sugyo, Yosuke Harada, Satoshi Nagayama, Toyomasa Katagiri, Yusuke Nakamura, Tatsuya Higashi. Head-to-head comparison of three chelates reveals DOTAGA promising for 225 Ac labeling of anti-FZD10 antibody OTSA101. Cancer science. 2023. 114. 12. 4677-4690
  • Atsushi Saito, Yasunao Kamikawa, Taichi Ito, Koji Matsuhisa, Masayuki Kaneko, Takumi Okamoto, Tetsuro Yoshimaru, Yosuke Matsushita, Toyomasa Katagiri, Kazunori Imaizumi. p53-independent tumor suppression by cell-cycle arrest via CREB/ATF transcription factor OASIS. Cell reports. 2023. 42. 5. 112479-112479
  • Makoto Takeuchi, Toshihiko Nishisho, Shunichi Toki, Shinji Kawaguchi, Shunsuke Tamaki, Takeshi Oya, Yoshihiro Uto, Toyomasa Katagiri, Koichi Sairyo. Blue light induces apoptosis and autophagy by promoting ROS-mediated mitochondrial dysfunction in synovial sarcoma. Cancer medicine. 2023. 12. 8. 9668-9683
  • Kosaku Okuda, Kengo Nakahara, Akihiro Ito, Yuta Iijima, Ryosuke Nomura, Ashutosh Kumar, Kana Fujikawa, Kazuya Adachi, Yuki Shimada, Satoshi Fujio, et al. Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis. Nature communications. 2023. 14. 1. 621-621
more...
MISC (131):
more...
Lectures and oral presentations  (145):
  • 筋層浸潤性膀胱癌・多段階進展機構におけるDDX31の重要性
    (泌尿器科分子・細胞研究会プログラム・抄録集 2024)
  • 乳がん細胞におけるO型糖鎖修飾を介したIRE1の恒常的活性化機構の解明と新規治療戦略の可能性
    (日本生化学会大会プログラム・講演要旨集 2023)
  • 全ゲノム塩基配列決定により明らかとなった日本人家族性乳癌の新たな潜在的感受性遺伝子(Whole-exome sequencing reveals new potential susceptibility gene for Japanese familial breast cancer)
    (日本癌学会総会記事 2023)
  • BIG3-PHB2の相互作用を標的とすることで、HER2陽性乳がんのトラスツズマブ耐性を克服できる(Targeting BIG3-PHB2 interaction overcomes trastuzumab-resistance in patients with HER2-positive breast cancer)
    (日本癌学会総会記事 2023)
  • ゴルジ体-小胞体連携による持続的小胞体ストレス応答を通じたがん微小環境制御機構と新規創薬開発(Tumor microenvironmental control via persistent ER stress response by Golgi-ER collaboration and new therapeutics)
    (日本癌学会総会記事 2023)
more...
Education (3):
  • 1998 - Osaka University Faculty of Medicine
  • 1989 - 1991 Kagawa University Graduate School of Agriculture
  • 1985 - 1989 Kagawa University Faculty of Agriculture
Professional career (1):
  • 医学博士 (大阪大学)
Work history (11):
  • 2023/04 - 現在 National Institutes of Biomedical Innovation, Health and Nutrition National Institutes of Biomedical Innovation
  • 2023/04 - 現在 徳島大学先端酵素学研究所 ゲノム医科学分野 教授
  • 2020/04 - 2023/03 Institute of Advanced Medical Sciences
  • 2016/04 - 2023/03 徳島大学先端酵素学研究所 ゲノム制御学分野 教授
  • 2012/04 - 2016/03 徳島大学疾患プロテオゲノム研究センター ゲノム制御学分野 教授
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page